Document ID: chunk:federal_register_of_legislation:F2025C00124:reg:52
Version: federal_register_of_legislation:F2025C00124
Segment Type: reg
Provision Reference: reg 52
Character Range: 75581–76256

52  Prescriptions directing special arrangement supply
  Despite the amendment of this instrument by the amending instrument:
 (a) a prescription written before 1 December 2024 for the special arrangement supply of an HSD pharmaceutical benefit that has an EFC transition drug continues, on and after that date, to be a prescription for a special arrangement supply of an HSD pharmaceutical benefit; and
 (b) for the purposes of supply of the pharmaceutical benefit, on or after 1 December 2024, on the basis of the prescription:
 (i) the pharmaceutical benefit is taken to be an HSD pharmaceutical benefit; and
 (ii) daunorubicin with cytarabine is taken to be a CAR drug.